Previous close | 92.09 |
Open | 92.45 |
Bid | 93.35 x 900 |
Ask | 93.97 x 1400 |
Day's range | 92.45 - 94.08 |
52-week range | 70.89 - 94.56 |
Volume | |
Avg. volume | 11,619,161 |
Market cap | 236.57B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 16.74 |
EPS (TTM) | 5.59 |
Earnings date | 28 Jul 2022 |
Forward dividend & yield | 2.76 (2.95%) |
Ex-dividend date | 14 Mar 2022 |
1y target est | 96.06 |
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.
Rates could spike sooner rather than later. Prepare your portfolio.
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.